期刊文献+

硫氧还蛋白还原酶及其抑制剂的研究进展 被引量:7

Advances in thioredoxin reductase and its inhibitors
下载PDF
导出
摘要 硫氧还蛋白还原酶(thioredoxin reductase,TrxR)是存在于细胞中的含硒同型二聚体黄素酶,其主要功能为调节氧化还原平衡,与细胞的增殖、凋亡以及肿瘤的发生、转移、血管生成中密切相关。含硒C末端活性位点是TrxR的特有结合域,对TrxR与底物的结合具有重要作用,其靶向抑制剂正成为治疗与肿瘤相关疾病的研究热点。本文从TrxR的结构特点及其与肿瘤相关的生理功能出发,根据其与底物结合能力进行分类,将TrxR抑制剂分为可逆和不可逆两类,对两类抑制剂的最新研究进展进行了综述。 Thioredoxin reductase (TrxR) is a seleniferous homodimeric flavoenzyme, which is ubiquitously ex- pressed in all cells and plays a crucial role in the redox regulation of numerous celluar signaling pathways in- volved in cell survival and proliferation. TrxR maintains cellular redox equilibrium. Recent researches have illumi- nated that TrxR overexpressed in many tumors, is closely associated with the evolution, progression and apoptosis of tumor. TrxR contains a reactive and solvent accessible selenocysteine residue which is located on a flexible C- terminal arm of the protein. This selenocysteine is essentially involved in the catalytic cycle of TrxR and thus re- presents an attractive binding site for inhibitors, The TrxR inhibitors as novel target-drug in cancer therapy have been extensively studied and elucidated. This article summarized the latest progress in TrxR inhibitors according to the binding capacity of TrxR and substrate.
作者 吴石威 张惠 李乾斌 胡高云 WU Shiwei ZHANG Hui LI Qianbin HU Gaoyun(School of Pharmaceutical Sciences, Central South University, Changsha 410013 Hunan Provincial People's Hospital, Changsha 410005, China)
出处 《中国药科大学学报》 CAS CSCD 北大核心 2016年第5期511-520,共10页 Journal of China Pharmaceutical University
基金 国家自然科学基金资助项目(No.21102184 No.21172268 No.81573287) 国家"重大新药创制"科技重大专项资助项目(No.2012ZX09103101-025)~~
关键词 硫氧还蛋白还原酶 肿瘤 抑制剂 抗肿瘤药物 进展 thioredoxin reductase tumor inhibitors anti-tumor drugs advances
  • 相关文献

参考文献51

  • 1Lu J, Holmgren A. The thioredoxin antioxidant system [ J ]. Free Radic Biol Med,2014,66( SI) :75 -87.
  • 2Mahmood DF, Abderrazak A, EI Hadri K, et al. The thioredoxin system as a therapeutic target in human health and disease [ J ]. Antioxid Redox Signal,2013,19( 11 ) : 1266 - 1303.
  • 3Dal Piaz F, Braca A, Belisario MA, et al. Thioredoxin system modulation by plant and fungal secondary metabolites [ J ]. Curr Med Chem,2010,17 ( 5 ) :479 - 494.
  • 4Zhang BX, Duan DZ, Ge CP, et al. Synthesis of xanthohumol ana- lognes and discovery of potent thioredoxin reductase inhibitor as potential anticancer agent [ J ]. J Med Chem, 2015,58 (4) : 1795 - 1805.
  • 5Bindoli A, Rigobello MP. Principles in redox signaling: from chemistry to functional significance [ J ]. Antioxid Redox Signal,2013,18(13) :1557 - 1593.
  • 6Zhong L, Arn6r ES, Holmgren A. Structure and mechanism of mammalian thioredoxin reductase:the active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine- selenocysteine sequence [ J ]. Proc Natl Acad Sci U S A,2000,97 ( 11 ) :5854 -5859.
  • 7Sandalova T, Zhong L, Lindqvist Y, et al. Three-dimensional structure of a mammalian thioredoxin reduetase : implications for mechanism and evolution of a selenocysteine-dependent enzyme [J]. Proc Acad Sci U S A ,2001,98(17) :9533 -9538.
  • 8Urig S, Becker K. On the potential of thioredoxin reductase inhib- itors for cancer therapy [ J ]. Semin Cancer Biol, 2006,16 ( 6 ) : 452 - 465.
  • 9Arn6r ES, Holmgren A. The thioredoxin system in cancer [ J ]. Semin Cancer Biol,2006 ,16( 6 ) :420 -426.
  • 10Yoo MH,Xu XM, Carlson BA,et al Thioredoxinreductase 1 deft - ciency reverses tumor phenotype and tumor igenicity of lung car- cinoma cells[ J]. J Biol Chem ,2006 ,281 ( 19 ) :13005 - 13008.

同被引文献53

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部